Genetics and biomarker in bladder cancer for optimized clinical decision-making and improved outcomes
Standard
Genetics and biomarker in bladder cancer for optimized clinical decision-making and improved outcomes. / Rink, Michael.
in: TRANSL ANDROL UROL, Jahrgang 6, Nr. 6, 12.2017, S. 1014-1017.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Andere (Vorworte u.ä.) › Forschung
Harvard
Rink, M 2017, 'Genetics and biomarker in bladder cancer for optimized clinical decision-making and improved outcomes', TRANSL ANDROL UROL, Jg. 6, Nr. 6, S. 1014-1017. https://doi.org/10.21037/tau.2017.12.05
APA
Rink, M. (2017). Genetics and biomarker in bladder cancer for optimized clinical decision-making and improved outcomes. TRANSL ANDROL UROL, 6(6), 1014-1017. https://doi.org/10.21037/tau.2017.12.05
Vancouver
Rink M. Genetics and biomarker in bladder cancer for optimized clinical decision-making and improved outcomes. TRANSL ANDROL UROL. 2017 Dez;6(6):1014-1017. https://doi.org/10.21037/tau.2017.12.05
Bibtex
@article{b39fe4ec6548435da2c7c39c53ed5181,
title = "Genetics and biomarker in bladder cancer for optimized clinical decision-making and improved outcomes",
author = "Michael Rink",
note = "Editorial ",
year = "2017",
month = dec,
doi = "10.21037/tau.2017.12.05",
language = "English",
volume = "6",
pages = "1014--1017",
journal = "TRANSL ANDROL UROL",
issn = "2223-4683",
publisher = "AME Publishing Company",
number = "6",
}
RIS
TY - JOUR
T1 - Genetics and biomarker in bladder cancer for optimized clinical decision-making and improved outcomes
AU - Rink, Michael
N1 - Editorial
PY - 2017/12
Y1 - 2017/12
U2 - 10.21037/tau.2017.12.05
DO - 10.21037/tau.2017.12.05
M3 - Other (editorial matter etc.)
VL - 6
SP - 1014
EP - 1017
JO - TRANSL ANDROL UROL
JF - TRANSL ANDROL UROL
SN - 2223-4683
IS - 6
ER -
